In February 2024, the U.S. Food and Drug Administration (FDA) approved Xolair (Omalizumab) for patients 1 year of age and older at risk for immunoglobulin E (IgE)-mediated food allergic reactions after accidental exposure. Xolair has been on the market for 20 years, and at Schreiber Allergy, we ... Read more »
Blog
Food Allergy vs. Food Intolerance
Here at Schreiber Allergy, we are getting many questions and visits related to food intolerance. We hope that this post can answer some common questions regarding the differences between food allergy and food intolerance. It is true that adverse reactions to foods are very common. But it is ... Read more »
COVID-19 Vaccine Updates and More
Dear Patients,We are excited to see the Pfizer-BioNTech COVID-19 vaccine approved for children 5 to 11-years-old! Please contact your pediatricians for vaccine administration. We are not administering COVID-19 vaccines in our office. The dose that will be administered is 10mcg (the adolescent/adult ... Read more »
All things summer…
We can’t believe that it is already July! We hope all of our patients had a safe and fun holiday weekend. Summer and Food Allergies With the summer weather heating up, many families are spending time at barbeques, the pool, the beach, and at sleepaway and day camps. With COVID rates at ... Read more »
Allergic Reactions and the COVID Vaccines
The FDA has now approved two COVID-19 vaccines for emergency use which are available for some at-risk individuals. And with the first wave of vaccinations, there have been reports of allergic reactions and even anaphylaxis. Most importantly, all patients should know that reactions to ... Read more »
COVID-19 Vaccine Update
Dear Patients,We want to let you know that we are closely monitoring the reports about anaphylaxis to the COVID-19 vaccine. At this point we have limited data about the reactions, but we do know that allergic reactions to vaccines are rare. Although anaphylaxis to ... Read more »